Tweet Archive for March 2015 « page 7
Cosmetic innovations in the Guerlain patents deposited in the XIXth century. ncbi.nlm.nih.gov/pubmed/2580766… #cosmetics
Metals in cosmetics: implications for human health. ncbi.nlm.nih.gov/pubmed/2580947… #cosmetic
Subjective & Objective Measures in OnaBoNT-A Treatment of Hemifacial Spasm. Subjective vs. objective is the cool part ncbi.nlm.nih.gov/pubmed/2581116…
Evaluation of autoimmune thyroid disease in melasma. ncbi.nlm.nih.gov/pubmed/2581021… #dermatology
Influence of the complex of retinol-vitamin C on skin surface lipids. ncbi.nlm.nih.gov/pubmed/2581036… #menopause
Home Phototherapy for Psoriasis. @AADskin JAAD #dermatology how do you monitor cumulative UV dose? practiceupdate.com/journalscan/17… @practiceupdate
Collagen #dermalfiller will soon be back. Whether they made it vs HAs this is another story @EternoGen #AMWC2015 pic.twitter.com/DRRiF7QalI
RT001 (Botulinum Toxin Type A) Topical Gel for Treatment of Lateral Canthal Lines by Revance Therapeutics revance.com/rt001-lateral-…
Revance Provides Update on RT001 Clinical Program for Crow’s Feet Lines revance.com/news/revance-t… #cosmeticdermatology
From #AMWC2015 Topical BTX (RT001): where do we stand. Summary. #aestheticdermatology pic.twitter.com/PITL5aUBMy